Live Breaking News & Updates on புற்றுநோய் அறிவியல் நிறுவனம் ஆஃப் சிங்கப்பூர்

Stay updated with breaking news from புற்றுநோய் அறிவியல் நிறுவனம் ஆஃப் சிங்கப்பூர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Researchers Identify Potential Targets for Novel Treatments for Lung Cancer


Date Time
Researchers Identify Potential Targets for Novel Treatments for Lung Cancer
Lung cancer is the most common cause of cancer deaths, accounting for about a third of all tumor-related deaths. Adenocarcinomas, a non-small cell lung cancer (NSCLC), account for about 40 percent of cancer diagnoses, but few treatments are available for the disease.
A team of investigators led by Elena Levantini, PhD, a research associate in Hematology-Oncology in the laboratory of Daniel Tenen MD, at Beth Israel Deaconess Medical Center (BIDMC), evaluated a novel agent, PTC596, capable of decreasing tumor growth in preclinical studies performed on a mouse model of mutant K-RAS lung cancer. The research – performed in collaboration with the Cancer Science Institute of Singapore at the National University of Singapore (CSI NUS) – were published today in the journal Communications Biology. The findings, which represent a comprehensive snapshot of the tumor’s components, will faci ....

United States , National University Of Singapore , Singapore General , Junyan Zhang , Henry Yang , John Clohessy , Mahmoud Bassal , Jia Li , Azhar Ali , Eva Csizmadia , Nicole Pandell , Indira Krishnan , Raphael Bueno , Giorgia Maroni , Allon Klein , Danielg Tenen , Regione Toscana Bando , Riccardo Panella , Elena Levantini , Olivier Kocher , Valerie Myami , National Cancer Institute , Beth Israel Deaconess Medical Center , University Of Alabama At Birmingham , American Society Of Hematology , Cancer Science Institute Of Singapore ,

Singapore finds way to improve treatment outcomes for breast cancer

Asian-relevant lung cancer research presented at Global Lung Cancer Conference hosted in Singapore


 E-Mail
Lung cancer continues to be the leading cause of cancer death in Singapore and the world.
The World Conference on Lung Cancer, the largest international gathering of clinicians, researchers and scientists in the field of lung cancer - with more than 6,000 participants - was held from 28 January to 31 January 2021 as a worldwide virtual event hosted by Singapore.
A group of Singapore clinicians and scientists presented new data to enhance understanding and treatment of lung cancer in the Asian population at the conference.
SINGAPORE, 1 FEBRUARY 2021 - Clinicians and scientists from Singapore shared exciting new data on lung cancer treatment in the Asian population at the World Conference on Lung Cancer Singapore, last week. Lung cancer develops very differently in Western and Asian populations, which makes understanding the disease from an Asian perspective a research priority for Singapore and the region. ....

Gillianne Lai , Anders Skanderup , Agency For Science , National Research Foundation Singapore , Consultant In Division Of Medical Oncology , Lung Cancer Open Fund , National Cancer Centre Singapore , Genome Institute Of Singapore , Cancer Science Institute Of Singapore , Epidemiological Sciences , Division Of Medical Oncology , National University Hospital Singapore , Singapore Immunology Network , National University Cancer Institute Singapore , World Conference , Lung Cancer , Lung Cancer Singapore , Collaborative Grant , Associate Professor Daniel Tan , Senior Consultant , Medical Oncology , Singapore Ministry , National Medical Research Council , Cancer Science Institute , Genome Institute , Assoc Prof Tan ,